4//SEC Filing
Kim Dong 4
Accession 0001437749-24-003014
CIK 0001668243other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:05 PM ET
Size
8.8 KB
Accession
0001437749-24-003014
Insider Transaction Report
Form 4
Kim Dong
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2024-01-31+3,333→ 26,585 total - Exercise/Conversion
Restricted Stock Units
2024-01-31−3,333→ 6,667 total→ Ordinary Shares (3,333 underlying) - Award
Restricted Stock Units
2024-01-31+12,000→ 12,000 total→ Ordinary Shares (12,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
- [F3]1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.
Documents
Issuer
UroGen Pharma Ltd.
CIK 0001668243
Entity typeother
Related Parties
1- filerCIK 0001920163
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 7:05 PM ET
- Size
- 8.8 KB